146 related articles for article (PubMed ID: 2129311)
1. Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa?
Baranowska B
Psychoneuroendocrinology; 1990; 15(5-6):371-9. PubMed ID: 2129311
[TBL] [Abstract][Full Text] [Related]
2. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
[TBL] [Abstract][Full Text] [Related]
3. The effect of clonidine on hormone release mediated through activation of opiate receptors.
Baranowska B
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1113-7. PubMed ID: 1964578
[TBL] [Abstract][Full Text] [Related]
4. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity.
Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W
Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310
[TBL] [Abstract][Full Text] [Related]
5. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
6. Clonidine stimulation in anorexia nervosa: growth hormone, cortisol, and beta-endorphin responses.
Brambilla F; Lampertico M; Sali L; Cavagnini F; Invitti C; Maggioni M; Candolfi C; Panerai AE; Müller EE
Psychiatry Res; 1987 Jan; 20(1):19-31. PubMed ID: 2951760
[TBL] [Abstract][Full Text] [Related]
7. The effect of clonidine on pituitary hormone secretion in physiological and pathological states.
Baranowska B
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S235-9. PubMed ID: 2455186
[TBL] [Abstract][Full Text] [Related]
8. Steroids and neuroendocrine function in anorexia nervosa.
Casanueva FF; Borras CG; Burguera B; Muruais C; Fernández M; Devesa J
J Steroid Biochem; 1987; 27(1-3):635-40. PubMed ID: 3121928
[TBL] [Abstract][Full Text] [Related]
9. Opioid regulation of pituitary gonadotropins and prolactin in women using oral contraceptives.
Snowden EU; Khan-Dawood FS; Dawood MY
Am J Obstet Gynecol; 1986 Feb; 154(2):440-4. PubMed ID: 3080893
[TBL] [Abstract][Full Text] [Related]
10. Delayed pituitary hormone response to LRF and TRF in patients with anorexia nervosa and with secondary amenorrhea associated with simple weight loss.
Vigersky RA; Loriaux DL; Andersen AE; Mecklenburg RS; Vaitukaitis JL
J Clin Endocrinol Metab; 1976 Oct; 43(4):893-900. PubMed ID: 824302
[TBL] [Abstract][Full Text] [Related]
11. A study on the effects of interaction between naloxone and 2-Br-alpha-ergocryptine or clonidine on luteinizing hormone, follicle-stimulating hormone, prolactin and thyroid-stimulating hormone levels in normal man serum.
Agnati LF; Benfenati F; Cortelli P; D'alessandro R; Ghisoli E; Zampa GA
Neurosci Lett; 1979 May; 12(2-3):307-11. PubMed ID: 223091
[TBL] [Abstract][Full Text] [Related]
12. Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men.
Lal S; Tolis G; Martin SB; Brown GM; Guyda H
J Clin Endocrinol Metab; 1975 Nov; 41(5):827-32. PubMed ID: 1184719
[TBL] [Abstract][Full Text] [Related]
13. Anterior pituitary responsiveness to hypothalamic hormones in anorexia nervosa.
Brambilla F; Cocchi D; Nobile P; Müller EE
Neuropsychobiology; 1981; 7(5):225-37. PubMed ID: 6796900
[TBL] [Abstract][Full Text] [Related]
14. Influence of naloxone infusion on prolactin and growth hormone response to growth hormone-releasing hormone in anorexia nervosa.
De Marinis L; Mancini A; D'Amico C; Zuppi P; Tofani A; Della Casa S; Saporosi A; Sambo P; Fiumara C; Calabró F
Psychoneuroendocrinology; 1991; 16(6):499-504. PubMed ID: 1811245
[TBL] [Abstract][Full Text] [Related]
15. Body weight and the pituitary response to hypothalamic releasing hormones in patients with anorexia nervosa.
Beumont PJ; George GC; Pimstone BL; Vinik AI
J Clin Endocrinol Metab; 1976 Sep; 43(3):487-96. PubMed ID: 821959
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa.
Maeda K; Kato Y; Yamaguchi N; Chihara K; Ohgo S
Acta Endocrinol (Copenh); 1976 Jan; 81(1):1-8. PubMed ID: 813470
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological evidence for opioid and adrenergic mechanisms controlling growth hormone, prolactin, pancreatic polypeptide, and catecholamine levels in humans.
Thompson DA; Pénicaud L; Welle SL; Jacobs LS
Metabolism; 1985 Apr; 34(4):383-90. PubMed ID: 3982277
[TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
[TBL] [Abstract][Full Text] [Related]
19. Endogenous opioid peptides and the control of the menstrual cycle.
Ferin M; Vande Wiele R
Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):365-73. PubMed ID: 6098492
[TBL] [Abstract][Full Text] [Related]
20. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers.
Naber D; Pickar D; Davis GC; Cohen RM; Jimerson DC; Elchisak MA; Defraites EG; Kalin NH; Risch SC; Buchsbaum MS
Psychopharmacology (Berl); 1981; 74(2):125-8. PubMed ID: 6267643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
